Orsini Partners with ITVISMA® to Enhance Treatment Options for SMA Patients Orsini has been announced as a specialty pharmacy partner for ITVISMA®, a groundbreaking gene therapy for spinal muscular atrophy, expanding treatment options for patients aged two and older.

Orsini Partners with ITVISMA® to Enhance Treatment Options for SMA Patients #United_States #Elk_Grove_Village #Orsini #Itvisma #SMA_Treatment